Company / Operating Income
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Operating Income History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$2.4M
FY2015
5-year range
-$2.4M / -$881.7K
FY2011-FY2015
Trend
-14.1%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has declined for 3 consecutive years, from -$881,684 in FY2011 to -$2M in FY2015.
Based on SEC 10-K filings.
-$2M in FY2015.
Declined from -$2M to -$2M over the past 3 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- LIXTE BIOTECHNOLOGY HOLDINGS, INC.'s operating income has declined for 3 consecutive years.
- In FY2015, operating income decreased 14.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score -11.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2015 | -$2.4M | -14.1% |
| FY2013 | -$2.1M | -12.7% |
| FY2012 | -$1.9M | -111.9% |
| FY2011 | -$881.7K | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026